Skip to content

FP7HORIZONH2020

Hadassah Medical Organization

Country
ILIsrael
Defence projects
0
Projects, all programmes
23
As coordinator
7
EU contribution (CORDIS)
EUR 8,992,160
Active
2008 to 2025

Projects

23 projects, newest first

Projects, newest first
ProjectProgrammeYearRoleEU contribution
AHEADAI for Health: Evaluation of Applications & DatasetsHORIZON2025ParticipantEUR 23,000
IMMERGEStorming Immune Monogenic Conditions through Multiomic and Gene Editing ApproachesHORIZON2024Associated partnerEUR 0
EPICEnhancing palliative care in ICUHORIZON2024ParticipantEUR 310,625
DDG-MRIDDG-MRI for cancer detection - A novel medical imaging approach that correlates to FDG-PET without ionising radiationHORIZON2024CoordinatorEUR 500,000
RESPONSEEarly detection of treatment response in breast cancerHORIZON2024ParticipantEUR 499,944
BETTERBetter rEal-world healTh-daTa distributEd analytics Research platformHORIZON2023ParticipantEUR 548,500
VALIDATEV A L I D A T E - Validation of a Trustworthy AI-based Clinical Decision Support System for Improving Patient Outcome in Acute Stroke TreatmentHORIZON2022ParticipantEUR 700,000
CANCERNARNA PROCESSING FOR ANTI-CANCER IMMUNOTHERAPYHORIZON2022CoordinatorEUR 877,500
AlternativesToGdHyperpolarised MR technologies and molecular probes as alternatives for conventional metal-containing contrast agents for MRI examinationsH20202019CoordinatorEUR 440,870
NextGenVisTraining the Next Generation of European Visual Neuroscientists for the benefit of innovation in health care and high-tech industryH20202015ParticipantEUR 260,301
Hyperpolarized MRICiticoline and deoxyglucose as new molecular imaging probes of DNP hyperpolarized MRI for cancer and neuroimagingFP72013CoordinatorEUR 1,650,000
TRIGGERKing of hearts, joints and lungs; periodontal pathogens as etiologic factor in RA, CVD and COPD and their impact on treatment strategiesFP72013ParticipantEUR 483,600
OrientationOrientation and disorientation in health and diseaseFP72013CoordinatorEUR 164,378
TAILORED-TREATMENTDEVELOPMENT OF TAILORED ANTIMICROBIAL TREATMENT REGIMENS AND NOVEL HOST- PATHOGEN INSIGHTS FOR RESPIRATORY TRACT INFECTIONS AND SEPSISFP72013ParticipantEUR 496,381
LITERACYONLINE PORTAL FOR E-LEARNING AND SUPPORTING SOCIAL INCLUSION OF PEOPLE WITH DYSLEXIAFP72012ParticipantEUR 88,663
VACTRAINTraining network for next generation vaccinologistsFP72012ParticipantEUR 237,814
CAV IN IMMUNE SYSTEMMolecular mechanism of calcium entry in the immune systemFP72011CoordinatorEUR 100,000
MVP-GENGenetics of mitral valve prolapseFP72011CoordinatorEUR 100,000
TAM IN AMDRole of TAM signaling in Retinal HomeostasisFP72010ParticipantEUR 27,083
EDU-GLIAInnovative Techniques and Models to Study Glia-Neuron InteractionsFP72009ParticipantEUR 395,031

The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.

Where this comes from

EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.

Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.

Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.